The post MS disease modifying therapy, Aubagio® (teriflunomide), to be delisted appeared first on MS Research Australia.
The post Partnership grant to improve decisions about accessing stem cell-based therapies appeared first on MS Research Australia.
The post FDA Backs Development of Blood Biomarker for Clinical Trials in Progressive MS appeared first on MS Research Australia.
1300 356 467[email protected]
We're not around right now. But you can send us an email and we'll get back to you, asap.
Start typing and press Enter to search